Gefitinib Molecular Model

Gefitinib Molecular Model

C017/6413 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 17.6MB

Downloadable file size: 430.3KB

Price image Pricing

Please login to use the price calculator



Caption: Molecular model of gefitinib. Gefitinib is a new medicine; a selective inhibitor of the epidermal growth factor receptor's (EGFR) tyrosine kinase domain. It binds to the adenosine triphosphate (ATP) binding site of the enzyme and in this way inhibits the growth of malignant cells. C22 H24 Cl F N4 O3. Carbon in grey; Hydrogen in white; Nitrogen in blue; Chlorine in yellow; Fluorine in green; Oxygen in red.

Release details: Model release not required. Property release not required.

Keywords: astrazeneca, atp, carbon, chemical, chemistry, chlorine, drug, egfr, epidermal growth factor receptor, fluorine, gefitinib, hydrogen, inhibitor of cell growth, iressa, medicine, molecular, molecular model, molecular modelling, molecule model, molecules, nitrogen, oxygen, selective inhibitor, teva, treatment, tyrosine kinase

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.